General Information of Drug Metabolite (DM) (ID: DM005607) |
DM Name |
Gavestinel acyl glucuronid
|
Structure |
|
3D MOL is unavailable
|
2D MOL is unavailable
|
|
|
|
|
|
|
|
Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
DME(s) Producing This DM through Metabolism |
DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
UDP-glucuronosyltransferase 1A1 (UGT1A1)
|
DME0004
|
| Conjugation - Glucuronidation |
GV-150526
|
[1] |
UDP-glucuronosyltransferase 1A3 (UGT1A3)
|
DME0041
|
| Conjugation - Glucuronidation |
GV-150526
|
[1] |
UDP-glucuronosyltransferase 1A9 (UGT1A9)
|
DME0042
|
| Conjugation - Glucuronidation |
GV-150526
|
[1] |
UDP-glucuronosyltransferase 2B4 (UGT2B4)
|
DME0047
|
| Conjugation - Glucuronidation |
GV-150526
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
Full List of Drug(s) That Produce This DM By Metabolism |
GV-150526 |
DR0763
|
Discontinued |
Cerebral stroke |
|
References |
1 |
Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.